Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer

por Selle, F., Gligorov, J., Richard, S., Khalil, A., Alexandre, I., Avenin, D., Provent, S., Soares, D.G., Lotz, J.P.
Publicado 2014

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

por Fajac, A, Gligorov, J, Rezai, K, Lévy, P, Lévy, E, Selle, F, Beerblock, K, Avenin, D, Saintigny, P, Hugonin, S, Bernaudin, J-F, Lokiec, F
Publicado 2010

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytored...

por Pautier, P., Floquet, A., Chevreau, C., Penel, N., Guillemet, C., Delcambre, C., Cupissol, D., Selle, F., Isambert, N., Piperno-Neumann, S., Saada-Bouzid, E., Bertucci, F., Bompas, E., Alexandre, J., Collard, O., Lebrun-Ly, V., Soulier, P., Toulmonde, M., Le Cesne, A., Lacas, B., Duffaud, F.
Publicado 2021

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group

por Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I
Publicado 2017